Atlas Trials

QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer

Clinical trial NCT06751277 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06751277
Sponsor
xiang yang
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent or Metastatic Endometrial Cancer
Start date
2025-02-01
Primary completion
2026-12-30
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.